BRPI0518372A2 - composto, composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço, e, uso de um composto - Google Patents

composto, composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço, e, uso de um composto

Info

Publication number
BRPI0518372A2
BRPI0518372A2 BRPI0518372-3A BRPI0518372A BRPI0518372A2 BR PI0518372 A2 BRPI0518372 A2 BR PI0518372A2 BR PI0518372 A BRPI0518372 A BR PI0518372A BR PI0518372 A2 BRPI0518372 A2 BR PI0518372A2
Authority
BR
Brazil
Prior art keywords
compound
composition
preparing
pharmaceutical composition
compounds
Prior art date
Application number
BRPI0518372-3A
Other languages
English (en)
Inventor
Roelof Van Hes
Pieter Smid
Cornelis G Kruse
Martinus Th M Tulp
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of BRPI0518372A2 publication Critical patent/BRPI0518372A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

COMPOSTO, COMPOSIÇçO FARMACÊUTICA, MÉTODO PARA PREPARAR UMA COMPOSIÇçO, E, USO DE UM COMPOSTO. A presente invenção diz respeito a um grupo de novos derivados de 3-(2-piperidin-4-il-etil)-1H-indol com um modo duplo de ação: inibição da reabsorção de serotonina e afinidade para receptores de dopamina- D2 e a métodos para a preparação destes compostos. A invenção também diz respeito ao uso de um composto divulgado neste para a fabricação de uma droga que dá um efeito benéfico. Os compostos têm a fórmula geral (1) em que os simbolos tem os significados dados na especificação.
BRPI0518372-3A 2004-12-07 2005-12-06 composto, composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço, e, uso de um composto BRPI0518372A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106361 2004-12-07
PCT/EP2005/056503 WO2006061374A1 (en) 2004-12-07 2005-12-06 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites

Publications (1)

Publication Number Publication Date
BRPI0518372A2 true BRPI0518372A2 (pt) 2008-11-18

Family

ID=34930008

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518372-3A BRPI0518372A2 (pt) 2004-12-07 2005-12-06 composto, composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço, e, uso de um composto

Country Status (15)

Country Link
EP (1) EP1824486B1 (pt)
JP (1) JP2008523028A (pt)
KR (1) KR20070087644A (pt)
CN (1) CN101072563A (pt)
AR (1) AR052332A1 (pt)
AT (1) ATE425754T1 (pt)
AU (1) AU2005313388A1 (pt)
BR (1) BRPI0518372A2 (pt)
CA (1) CA2587940A1 (pt)
MX (1) MX2007006758A (pt)
RU (1) RU2007125691A (pt)
SA (1) SA05260390B1 (pt)
TW (1) TW200631952A (pt)
WO (1) WO2006061374A1 (pt)
ZA (1) ZA200704156B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8063062B2 (en) 2006-12-20 2011-11-22 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition
WO2008084057A1 (en) * 2007-01-10 2008-07-17 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition
US8138174B2 (en) 2007-01-10 2012-03-20 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition
KR101387970B1 (ko) 2011-04-20 2014-04-25 인제대학교 산학협력단 암 예방 및 치료용 조성물 및 건강기능식품
WO2015014256A1 (en) 2013-07-29 2015-02-05 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
CN110041318B (zh) * 2018-01-17 2022-07-29 中国科学院上海药物研究所 一类多巴胺d5受体激动剂及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
JP2003524571A (ja) * 1997-07-25 2003-08-19 ハー・ルンドベック・アクチエゼルスカベット インドール−及び２，３−ジヒドロインドール誘導体、その製造方法及びその使用方法
NZ517900A (en) * 1999-08-23 2003-08-29 Solvay Pharm Bv Phenylpiperazines useful as serotonin reuptake inhibitors
DE10259244A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh N-(Indolethyl-)cycloamin-Verbindungen

Also Published As

Publication number Publication date
EP1824486A1 (en) 2007-08-29
KR20070087644A (ko) 2007-08-28
MX2007006758A (es) 2007-11-09
AU2005313388A1 (en) 2006-06-15
RU2007125691A (ru) 2009-01-20
EP1824486B1 (en) 2009-03-18
SA05260390B1 (ar) 2009-04-01
ZA200704156B (en) 2008-05-28
JP2008523028A (ja) 2008-07-03
WO2006061374A1 (en) 2006-06-15
CA2587940A1 (en) 2006-06-15
CN101072563A (zh) 2007-11-14
AR052332A1 (es) 2007-03-14
TW200631952A (en) 2006-09-16
ATE425754T1 (de) 2009-04-15

Similar Documents

Publication Publication Date Title
CA2661102C (en) Thiophene derivatives as s1p1/edg1 receptor agonists
EA201001733A1 (ru) Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк)
EA201001585A1 (ru) Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк)
WO2009074950A3 (en) Thiophene derivatives as agonists of s1p1/edg1
NO20083057L (no) Sulfonyl substituerte 1H-indoler som ligander til 5-hydroksytryptamin reseptorer
BRPI0606644A2 (pt) derivados de 4-carboxamida tiazola
UA96076C2 (en) Use of trans-clomiphene
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
MX2009000169A (es) Derivados de purinona como agonistas de hm74a.
EA200970065A1 (ru) Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38
PE20081831A1 (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
BRPI0909737A2 (pt) compostos de pirrolidinila, composição farmacêutica compreendendo os mesmos e usos dos mesmos
BRPI0514289A (pt) compostos orgánicos
CY1111460T1 (el) Μεθανοσουλφονικη 4-[(3-φθοροφαινοξυ) φαινυλο-μεθυλο] πιπεριδινη: χρησεις, διεργασια συνθεσης και φαρμακευτικες συνθεσεις
WO2009056707A3 (fr) Dérivés de l'ind0l-2-0ne disubstitues en 3, leur preparation et leur application en thérapeutique
BRPI0518613A2 (pt) compostos, composiÇço farmacÊutica, mÉtodo de preparar uma composiÇço, e, uso de um composto
TW200637817A (en) 5-aminoindole derivatives
EA200971017A1 (ru) Аминоалкоксиарилсульфонамидные соединения и их применение в качестве 5-нтлигандов
BRPI0518370A2 (pt) composto, composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço, e, uso de um composto
GEP20146025B (en) Chromenone derivatives as trpv3 antagonists
TW200631952A (en) Benzdioxan piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
AU2009211506A1 (en) Novel imidazolinylmethyl aryl sulfonamides
BRPI0520579B8 (pt) composto, processo para a preparação de um composto e composição farmacêutica
BRPI0518620A2 (pt) compostos, composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço, e, uso de um composto
CY1111560T1 (el) Παραγωγα καρβαζολιου ως λειτουργικα συμπλοκα 5-ητ6

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.